Maria G. Cipolleschi

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

The unveiling of the Warburg effect and the inscribed innovative approach to a radical non toxic anticancer therapy.

The unveiling of the Warburg effect and the inscribed innovative approach to a radical non toxic anticancer therapy.

Journal: Cell cycle (Georgetown, Tex.)

Published: November 22, 2017

Low-dose methotrexate enhances cycling of highly anaplastic cancer cells.

Low-dose methotrexate enhances cycling of highly anaplastic cancer cells.

Journal: Cell cycle (Georgetown, Tex.)

Published: November 15, 2016

Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway.

Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway.

Journal: Cell adhesion & migration

Published: September 03, 2016

Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction.

Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction.

Journal: Oncotarget

Published: August 11, 2016

Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells.

Chronic Myeloid Leukemia and Hepatoblastoma: Two Cancer Models to Link Metabolism to Stem Cells.

Journal: Frontiers in oncology

Published: January 12, 2016

Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells.

Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells.

Journal: Cell cycle (Georgetown, Tex.)

Published: August 21, 2015

The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents.

The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents.

Journal: Oncotarget

Published: March 20, 2015

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.

Journal: Cell cycle (Georgetown, Tex.)

Published: December 09, 2014

One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment.

One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a "hypoxic" environment.

Journal: Hypoxia (Auckland, N.Z.)

Published: January 21, 2014

Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets.

Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets.

Journal: Cell cycle (Georgetown, Tex.)

Published: November 09, 2013

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells.

Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells.

Journal: Oncogene

Published: April 16, 2013

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia.

AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia.

Journal: Cell death & disease

Published: March 16, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026